chrX-123184519-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_000828.5(GRIA3):c.-17T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000312 in 1,161,975 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 137 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00024 ( 0 hom., 6 hem., cov: 21)
Exomes 𝑓: 0.00032 ( 0 hom. 131 hem. )
Consequence
GRIA3
NM_000828.5 5_prime_UTR
NM_000828.5 5_prime_UTR
Scores
2
Splicing: ADA: 0.01408
2
Clinical Significance
Conservation
PhyloP100: 2.06
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant X-123184519-T-C is Benign according to our data. Variant chrX-123184519-T-C is described in ClinVar as [Benign]. Clinvar id is 1258859.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000235 (26/110433) while in subpopulation SAS AF= 0.000793 (2/2521). AF 95% confidence interval is 0.000265. There are 0 homozygotes in gnomad4. There are 6 alleles in male gnomad4 subpopulation. Median coverage is 21. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 6 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRIA3 | NM_000828.5 | c.-17T>C | 5_prime_UTR_variant | 1/16 | ENST00000622768.5 | NP_000819.4 | ||
GRIA3 | NM_007325.5 | c.-17T>C | 5_prime_UTR_variant | 1/16 | ENST00000620443.2 | NP_015564.5 | ||
GRIA3 | NM_001256743.2 | c.-17T>C | 5_prime_UTR_variant | 1/4 | NP_001243672.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRIA3 | ENST00000620443.2 | c.-17T>C | 5_prime_UTR_variant | 1/16 | 1 | NM_007325.5 | ENSP00000478489 | P4 | ||
GRIA3 | ENST00000622768.5 | c.-17T>C | 5_prime_UTR_variant | 1/16 | 5 | NM_000828.5 | ENSP00000481554 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000236 AC: 26AN: 110381Hom.: 0 Cov.: 21 AF XY: 0.000184 AC XY: 6AN XY: 32629
GnomAD3 genomes
AF:
AC:
26
AN:
110381
Hom.:
Cov.:
21
AF XY:
AC XY:
6
AN XY:
32629
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000487 AC: 79AN: 162269Hom.: 0 AF XY: 0.000678 AC XY: 37AN XY: 54539
GnomAD3 exomes
AF:
AC:
79
AN:
162269
Hom.:
AF XY:
AC XY:
37
AN XY:
54539
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000320 AC: 337AN: 1051542Hom.: 0 Cov.: 25 AF XY: 0.000400 AC XY: 131AN XY: 327206
GnomAD4 exome
AF:
AC:
337
AN:
1051542
Hom.:
Cov.:
25
AF XY:
AC XY:
131
AN XY:
327206
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000235 AC: 26AN: 110433Hom.: 0 Cov.: 21 AF XY: 0.000184 AC XY: 6AN XY: 32691
GnomAD4 genome
AF:
AC:
26
AN:
110433
Hom.:
Cov.:
21
AF XY:
AC XY:
6
AN XY:
32691
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at